These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2724644)

  • 1. Should levodopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 parkinsonian patients treated with levodopa over 14 years.
    Indo T; Takahashi A
    Jpn J Med; 1989; 28(1):30-3. PubMed ID: 2724644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of long-term L-dopa therapy in 122 cases of Parkinson's disease over 14 years--when should L-dopa therapy be initiated?
    Indo T; Takahashi A
    Jpn J Med; 1986 May; 25(2):114-21. PubMed ID: 3747258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual manifestations of Parkinson's disease after ten or more years of levodopa.
    Klawans HL
    Mov Disord; 1986; 1(3):187-92. PubMed ID: 3504244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years].
    Indo T; Takahashi A
    Rinsho Shinkeigaku; 1987 Nov; 27(11):1419-22. PubMed ID: 3447802
    [No Abstract]   [Full Text] [Related]  

  • 7. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
    Marsden CD; Parkes JD
    Lancet; 1976 Feb; 1(7954):292-6. PubMed ID: 55599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF; Bergsrud D; Elton RL; Racy A
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease.
    Reichmann H; Brecht MH; Köster J; Kraus PH; Lemke MR
    CNS Drugs; 2003; 17(13):965-73. PubMed ID: 14533946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical observations in early and late onset Parkinson's disease.
    Bostantjopoulou S; Logothetis J; Katsarou Z; Mentenopoulos G
    Funct Neurol; 1991; 6(2):145-9. PubMed ID: 1916456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
    Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and clinical correlates of retrocollis in Parkinson's disease.
    Kashihara K; Imamura T
    J Neurol Sci; 2013 Jan; 324(1-2):106-8. PubMed ID: 23151424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC; Horstink MW; Roos RA; Jansen EN
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality associated with early and late levodopa therapy initiation in Parkinson's disease.
    Scigliano G; Musicco M; Soliveri P; Piccolo I; Girotti F; Giovannini P; Caraceni T
    Neurology; 1990 Feb; 40(2):265-9. PubMed ID: 2300246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
    Ricciardi L; Bove F; Espay KJ; Lena F; Modugno N; Poon YY; Krikorian R; Espay AJ; Fasano A
    Mov Disord; 2016 Apr; 31(4):597-8. PubMed ID: 26946221
    [No Abstract]   [Full Text] [Related]  

  • 19. Some new aspects of the effect of (-)deprenyl in Parkinson's disease--a retrospective study.
    Málly J
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):155-64. PubMed ID: 1571079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report.
    Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1991; 31 Suppl 1():3-16. PubMed ID: 1906808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.